Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Emergent Biosolutions (EBS)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for EBS as compared to
Top Competitors
Biotechnology
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
217M
HIGH
EBITDA
►
47.9M
HIGH
Net Income
►
25.8M
VERY HIGH
Revenue Growth
►
-6.8%
AVG
Net Income Growth
►
-45%
LOW
Operating Margin
►
19%
HIGH
Net Margin
►
11.9%
HIGH
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.346
AVG
Current Ratio
►
3.41
AVG
Quick Ratio
►
3.13
AVG
Interest Coverage Ratio
►
676
VERY HIGH
Book Value Per Share
►
7.62
Cash Per Share
►
3.85
Loading...
STOCK SUMMARY
Open
13.84
Day Range
13.75
-
14.36
52 Week Range
9.15
-
27.00
Volume
70K
Avg Volume (3 mo)
299K
Shares Outstanding
30.8M
Market Cap
438M
VALUATION
Price to Earnings (P/E)
►
16.5
AVG
Price to Book (P/B)
►
1.81
AVG
Price to Sales (P/S)
►
1.97
AVG
Return on Assets (ROA)
►
8.6%
HIGH
Return on Equity (ROE)
►
12.1%
AVG
EV/EBITDA
►
11.7
AVG
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
-1.4%
Net Insider Buying 6mo
-1.8%
Net Insider Buying 1yr
-1.9%
Held by insiders
73.1%
Held by institutions
35.9%
No Sales Breakout Data.